Global Single-Cell Genomics Market
Published Date:Nov 2025
Industry: Healthcare
Regions:
North America,
Europe,
Asia-Pacific,
Latin America,
Middle East & Africa
Format: PDF
Page: 200
Forecast Period: 2025-2033
Historical Range: 2020-2024
Global Single-Cell Genomics
Market Segmentation, By Product Type (Instruments {Single-cell Isolation &
Dispensing Systems, Polymerase Chain Reaction (PCR) Systems, Next-Generation
Sequencing (NGS) Platforms, Microarrays, High-Content Screening Systems}, Consumables
{Assay Kits & Reagents, Beads & Microplates}, Software & Services),
By Technology (Single-Cell RNA Sequencing (scRNA-seq), Single-Cell DNA
Sequencing (scDNA-seq), Single-Cell ATAC Sequencing (scATAC-seq), Single-Cell
Genome Sequencing, Single-Cell Transcriptomics, Flow Cytometry, Mass
Spectrometry (CyTOF)), By Workflow (Single-Cell Isolation & Capture, Sample
Preparation, Genomic Analysis, Data Analysis & Interpretation), By
Application (Oncology {Tumor Heterogeneity, Cancer Genomics}, Immunology, Neurology,
Stem Cell Research, Developmental Biology, Others), By End-User (Academic &
Research Institutes, Biotechnology & Pharmaceutical Companies, Hospitals
& Diagnostic Laboratories, Contract Research Organizations (CROs))-
Industry Trends and Forecast to 2033
Global Single-Cell Genomics
Market size was valued at USD 2042.7 million in 2024 and is expected to reach at
USD 10521.7 million in 2033, with a CAGR of 16.7% during the forecast period of
2025 to 2033.
Global Single-Cell Genomics Market Overview
The global Single-Cell Genomics
market is experiencing robust growth driven by advancements in next-generation
sequencing (NGS), microfluidics, and bioinformatics. This technology enables
detailed analysis of individual cells, providing crucial insights into cellular
diversity, disease mechanisms, and gene expression. Rising applications in
oncology, immunology, neurology, and precision medicine are accelerating
adoption. Increasing government and private funding for genomic research, along
with growing collaborations between biotech firms and research institutes, are
further boosting market expansion. However, high costs, data complexity, and
lack of standardization remain key challenges. Overall, the market continues to
evolve as single-cell technologies advance toward clinical utility.
Global Single-Cell Genomics Market Scope
|
Global Single-Cell
Genomics Market |
|||
|
Years
Considered |
|||
|
Historical Period |
2020 - 2023 |
Market Size (2024) |
USD 2042.7 Million |
|
Base Year |
2024 |
Market Size
(2033) |
USD 10521.7 Million |
|
Forecast Period |
2025 - 2033 |
CAGR (2025 – 2033) |
16.7% |
|
Segments
Covered |
|||
|
By Product Type |
·
Instruments o Single-cell
Isolation & Dispensing Systems o Polymerase
Chain Reaction (PCR) Systems o Next-Generation
Sequencing (NGS) Platforms o Microarrays o High-Content
Screening Systems ·
Consumables o Assay
Kits & Reagents o Beads
& Microplates ·
Software & Services |
||
|
By Technology |
·
Single-Cell
RNA Sequencing (scRNA-seq) ·
Single-Cell
DNA Sequencing (scDNA-seq) ·
Single-Cell
ATAC Sequencing (scATAC-seq) ·
Single-Cell
Genome Sequencing ·
Single-Cell
Transcriptomics ·
Flow
Cytometry ·
Mass
Spectrometry (CyTOF |
||
|
By Work Flow |
·
Single-Cell Isolation & Capture ·
Sample Preparation ·
Genomic Analysis ·
Data Analysis & Interpretation |
||
|
By Application |
·
Oncology o Tumor Heterogeneity o Cancer Genomics ·
Immunology ·
Neurology ·
Stem
Cell Research ·
Developmental
Biology ·
Others |
||
|
By End Users |
·
Academic & Research Institutes ·
Biotechnology & Pharmaceutical Companies ·
Hospitals & Diagnostic Laboratories ·
Contract Research Organizations (CROs) |
||
|
Countries
Catered |
|||
|
North America |
·
United States ·
Canada ·
Mexico |
||
|
Europe |
·
United
Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest
of Europe |
||
|
Asia Pacific |
·
China ·
India ·
Japan ·
Australia ·
South Korea ·
Rest of Asia Pacific |
||
|
Latin America |
·
Brazil ·
Argentina ·
Rest
of Latin America |
||
|
Middle East & Africa
|
·
Saudi Arabia ·
South Africa ·
Rest of MEA |
||
|
Key Companies |
|||
|
·
Thermo Fisher Scientific Inc. ·
NanoString Technologies, Inc. |
|||
Global Single-Cell Genomics Market Dynamics
The global Single-Cell Genomics
market dynamics are shaped by rapid technological advancements, growing
research applications, and increasing demand for personalized medicine. Key
drivers include the expanding use of single-cell sequencing in cancer research,
stem cell biology, immunology, and infectious disease studies. The technology
enables high-resolution cellular profiling, helping researchers uncover genetic
heterogeneity and disease progression at an unprecedented level. The
integration of artificial intelligence (AI), bioinformatics, and microfluidics
has further enhanced data analysis accuracy, scalability, and throughput.
Additionally, rising investments from governments, research institutions, and
biopharmaceutical companies are fueling innovation and infrastructure
development in genomics research.
However, the market faces
challenges such as high instrument and reagent costs, complex data
interpretation, and the need for specialized computational tools and skilled
professionals. Ethical and data privacy concerns also restrict large-scale
adoption in clinical applications. Nonetheless, emerging trends like spatial
genomics, single-cell multi-omics integration, and automation in sample
processing are creating significant growth opportunities. Furthermore, the
rising focus on precision medicine and biomarker discovery is expected to drive
widespread adoption across healthcare and diagnostics. Overall, the market is
poised for sustained growth, supported by continuous innovation, collaborative
research initiatives, and the expanding scope of genomic applications across
clinical and translational research.
Global Single-Cell Genomics
Market Segment Analysis
The global Single-Cell Genomics
market segment analysis reveals a comprehensive landscape shaped by diverse
technologies, applications, and end-users driving innovation and adoption. By
product type, the market is categorized into instruments, consumables, and
software & services. Instruments, including single-cell isolation and
dispensing systems, PCR systems, next-generation sequencing (NGS) platforms,
microarrays, and high-content screening systems, dominate due to their critical
role in enabling high-throughput and precise cellular analysis. Consumables
such as assay kits, reagents, beads, and microplates are witnessing increasing
demand driven by frequent usage in sequencing and analytical workflows.
Meanwhile, software and bioinformatics services are expanding rapidly,
addressing the growing need for efficient data analysis, visualization, and
interpretation of single-cell datasets.
By technology, the market
includes single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing
(scDNA-seq), single-cell ATAC sequencing (scATAC-seq), single-cell genome
sequencing, single-cell transcriptomics, flow cytometry, and mass spectrometry
(CyTOF). Among these, scRNA-seq holds the largest share, enabling in-depth
analysis of cellular gene expression and heterogeneity. The integration of
multi-omics technologies is also transforming biological discovery and disease
profiling.
By workflow, the market
encompasses single-cell isolation & capture, sample preparation, genomic
analysis, and data analysis & interpretation. Single-cell isolation and
genomic analysis are key stages, driven by innovations in microfluidics and sequencing
chemistry.
By application, the market serves
areas such as oncology, immunology, neurology, stem cell research, and
developmental biology. Oncology dominates due to applications in tumor
heterogeneity and cancer genomics, while immunology and stem cell research are
rapidly growing segments supporting drug discovery and regenerative medicine.
By end-user, the market is
segmented into academic & research institutes, biotechnology &
pharmaceutical companies, hospitals & diagnostic laboratories, and contract
research organizations (CROs). Academic institutions lead in research adoption,
while pharmaceutical companies increasingly use single-cell technologies for
biomarker discovery, drug target validation, and precision medicine
development. Overall, growing cross-sector collaboration, technological
integration, and clinical translational research continue to propel the
market’s global expansion.
Global Single-Cell Genomics
Market Regional Analysis
The global Single-Cell Genomics
market regional analysis highlights North America as the dominant region,
driven by advanced research infrastructure, strong funding for genomics
projects, and the presence of major biotechnology and sequencing companies. The
U.S. leads in adoption due to its extensive focus on cancer genomics,
immunology, and precision medicine initiatives. Europe follows closely,
supported by government-funded genomic programs and academic–industry
collaborations across countries such as the U.K., Germany, and France.
Asia-Pacific is projected to register the fastest growth, fueled by rising
investments in biotechnology, expanding genomic research in China, Japan, and
India, and the growing implementation of single-cell sequencing in clinical
studies. Meanwhile, Latin America and the Middle East & Africa are emerging
markets, gradually adopting single-cell technologies for healthcare and
biomedical research. Increasing collaborations, declining sequencing costs, and
technological advancements across these regions continue to strengthen the
global single-cell genomics ecosystem.
Global Single-Cell Genomics Market Key Players
·
10x Genomics
·
Illumina, Inc.
·
Fluidigm Corporation
·
Bio-Rad Laboratories, Inc.
·
Thermo Fisher Scientific Inc.
·
BGI Genomics Co., Ltd.
·
Takara Bio, Inc.
·
NanoString Technologies, Inc.
·
QIAGEN N.V.
·
Oxford Nanopore Technologies
·
PerkinElmer, Inc.
·
Roche Sequencing Solutions
Recent Developments
On July 9, 2024, Illumina,
Inc. announced the acquisition of Fluent BioSciences, a move aimed at
enhancing its position in the rapidly expanding single-cell genomics market.
This acquisition strengthens Illumina’s single-cell analysis capabilities and
supports its strategic vision to make multi-omics workflows more accessible to
researchers and clinical users. Fluent BioSciences is known for its innovative
instrument-free single-cell analysis technology, which simplifies sample
preparation and reduces the cost and complexity associated with single-cell
sequencing.
On November 6, 2024, CS
Genetics launched its groundbreaking “SimpleCell™ 3′ Gene Expression Kits,”
marking a major advancement in the field of single-cell transcriptomics. This
innovative solution eliminates the need for complex instrumentation, making
single-cell analysis more accessible, cost-effective, and scalable for
laboratories of all sizes. The SimpleCell platform enables researchers to
perform single-cell RNA sequencing (scRNA-seq) workflows with simplified setup
and reduced technical barriers, allowing for high-throughput gene expression
profiling across diverse cell types.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
Table of Contents
Chapter 1. Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Regulatory Scenario
1.4. Executive Summary
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Secondary Analyst Tools and Models
Chapter 3. Market Dynamics
3.1. Market
driver analysis
3.1.1. Advancements
in Next-Generation Sequencing (NGS)
3.1.2. Growing
Focus on Precision Medicine
3.2. Market
restraint analysis
3.2.1. High
Cost of Equipment and Reagents
3.3. Market
Opportunity
3.3.1. Increasing
genomic research infrastructure in Asia-Pacific and Latin America
3.4. Market
Challenges
3.4.1. Shortage
of Skilled Professionals
Chapter 4. Market Variables and Outlook
4.1. SWOT
Analysis
4.1.1. Strengths
4.1.2. Weaknesses
4.1.3. Opportunities
4.1.4. Threats
4.2. PESTEL
Analysis
4.2.1. Political
Landscape
4.2.2. Economic Landscape
4.2.3. Social
Landscape
4.2.4. Technological
Landscape
4.2.5. Environmental
Landscape
4.2.6. Legal
Landscape
4.3. Porter’s
Five Forces Analysis
4.3.1. Bargaining
Power of Suppliers
4.3.2. Bargaining
Power of Buyers
4.3.3. Threat
of Substitute
4.3.4. Threat
of New Entrant
4.3.5. Competitive
Rivalry
4.4. Value
Chain Analysis
4.5. Covid
Impact Analysis
Chapter 5. Single-Cell Genomics Market: Product Type Estimates
& Trend Analysis
5.1. Single-Cell
Genomics Market value share and forecast, (2020 to 2033)
5.2. Incremental
Growth Analysis and Infographic Presentation
5.3. Instruments
5.3.1. Single-cell
Isolation & Dispensing Systems
5.3.2. Polymerase
Chain Reaction (PCR) Systems
5.3.3. Next-Generation
Sequencing (NGS) Platforms
5.3.4. Microarrays
5.3.5. High-Content
Screening Systems
5.4. Consumables
5.4.1. Assay
Kits & Reagents
5.4.2. Beads
& Microplates
5.5. Software
& Services
Chapter 6. Single-Cell Genomics Market: Technology Estimates
& Trend Analysis
6.1. Single-Cell
Genomics Market value share and forecast, (2020 to 2033)
6.2. Incremental
Growth Analysis and Infographic Presentation
6.3. Single-Cell
RNA Sequencing (scRNA-seq)
6.4. Single-Cell
DNA Sequencing (scDNA-seq)
6.5. Single-Cell
ATAC Sequencing (scATAC-seq)
6.6. Single-Cell
Genome Sequencing
6.7. Single-Cell
Transcriptomics
6.8. Flow
Cytometry
6.9. Mass
Spectrometry (CyTOF)
Chapter 7. Single-Cell Genomics Market: Workflow Estimates
& Trend Analysis
7.1. Single-Cell
Genomics Market value share and forecast, (2020 to 2033)
7.2. Incremental
Growth Analysis and Infographic Presentation
7.3. Single-Cell
Isolation & Capture
7.4. Sample
Preparation
7.5. Genomic
Analysis
7.6. Data
Analysis & Interpretation
Chapter 8. Single-Cell Genomics Market: Application Estimates
& Trend Analysis
8.1. Single-Cell
Genomics Market value share and forecast, (2020 to 2033)
8.2. Incremental
Growth Analysis and Infographic Presentation
8.3. Oncology
8.3.1. Tumor
Heterogeneity
8.3.2. Cancer
Genomics
8.4. Immunology
8.5. Neurology
8.6. Stem
Cell Research
8.7. Developmental
Biology
8.8. Others
Chapter 9. Single-Cell Genomics Market: End User Estimates
& Trend Analysis
9.1. Single-Cell
Genomics Market value share and forecast, (2020 to 2033)
9.2. Incremental
Growth Analysis and Infographic Presentation
9.3. Academic
& Research Institutes
9.4. Biotechnology
& Pharmaceutical Companies
9.5. Hospitals
& Diagnostic Laboratories
9.6. Contract
Research Organizations (CROs)
Chapter 10. Single-Cell Genomics Market: Regional
Estimates & Trend Analysis
10.1. Single-Cell
Genomics Market value share and forecast, (2020 to 2033)
10.2. Incremental
Growth Analysis and Infographic Presentation
10.3. North
America
10.4. Europe
10.5. Asia
Pacific
10.6. Middle
East & Africa
10.7. Latin
America
Chapter 11. Single-Cell Genomics Market: Country
Estimates & Trend Analysis
11.1. Single-Cell
Genomics Market value share and forecast, (2020 to 2033)
11.2. Incremental
Growth Analysis and Infographic Presentation
11.3. United
States
11.4. Canada
11.5. Mexico
11.6. United
Kingdom
11.7. France
11.8. Germany
11.9. Italy
11.10. Spain
11.11. China
11.12. India
11.13. Japan
11.14. South
Korea
11.15. Australia
11.16. Brazil
11.17. Argentina
11.18. Saudi
Arabia
11.19. South
Africa
Chapter 12. Competitive Landscape
12.1. Company
Market Share Analysis
12.2. Vendor
Landscape
12.3. Competition
Dashboard
Chapter 13. Company Profiles
13.1. 10x
Genomics
13.1.1. Company
Overview
13.1.2. Financial
Details
13.1.3. Product
Analysis
13.1.4. Recent
Developments
13.2. Illumina,
Inc.
13.2.1. Company
Overview
13.2.2. Financial
Details
13.2.3. Product
Analysis
13.2.4. Recent
Developments
13.3. Fluidigm
Corporation
13.4. Bio-Rad
Laboratories, Inc.
13.4.1. Company
Overview
13.4.2. Financial
Details
13.4.3. Product
Analysis
13.4.4. Recent
Developments
13.5. Thermo
Fisher Scientific Inc.
13.5.1. Company
Overview
13.5.2. Financial
Details
13.5.3. Product
Analysis
13.5.4. Recent
Developments
13.6. BGI
Genomics Co., Ltd.
13.6.1. Company
Overview
13.6.2. Financial
Details
13.6.3. Product
Analysis
13.6.4. Recent
Developments
13.7. Takara
Bio, Inc.
13.7.1. Company
Overview
13.7.2. Financial
Details
13.7.3. Product
Analysis
13.7.4. Recent
Developments
13.8. NanoString
Technologies, Inc.
13.8.1. Company
Overview
13.8.2. Financial
Details
13.8.3. Product
Analysis
13.8.4. Recent
Developments
13.9. QIAGEN
N.V.
13.9.1. Company
Overview
13.9.2. Financial
Details
13.9.3. Product
Analysis
13.9.4. Recent
Developments
13.10. Oxford Nanopore Technologies
13.10.1.
Company Overview
13.10.2.
Financial Details
13.10.3.
Product Analysis
13.10.4.
Recent Developments
13.11. PerkinElmer,
Inc.
13.11.1.
Company Overview
13.11.2.
Financial Details
13.11.3.
Product Analysis
13.11.4.
Recent Developments
13.12.
Roche Sequencing Solutions
13.12.1.
Company Overview
13.12.2.
Financial Details
13.12.3.
Product Analysis
13.13. Recent Developments
Segmentation
Single-Cell
Genomics Market, Card Type Outlook (Revenue - USD Million, 2020 - 2033)
Instruments
·
Single-cell
Isolation & Dispensing Systems
·
Polymerase
Chain Reaction (PCR) Systems
·
Next-Generation
Sequencing (NGS) Platforms
·
Microarrays
·
High-Content
Screening Systems
Consumables
·
Assay
Kits & Reagents
·
Beads
& Microplates
Software
& Services
Single-Cell
Genomics Market, Technology Outlook (Revenue - USD Million, 2020 - 2033)
Single-Cell
RNA Sequencing (scRNA-seq)
Single-Cell
DNA Sequencing (scDNA-seq)
Single-Cell
ATAC Sequencing (scATAC-seq)
Single-Cell
Genome Sequencing
Single-Cell
Transcriptomics
Flow
Cytometry
Mass
Spectrometry (CyTOF)
Single-Cell
Genomics Market, Workflow Outlook (Revenue - USD Million, 2020 - 2033)
Single-Cell
Isolation & Capture
Sample
Preparation
Genomic
Analysis
Data
Analysis & Interpretation
Single-Cell
Genomics Market, Application Outlook (Revenue - USD Million, 2020 - 2033)
Oncology
·
Tumor
Heterogeneity
·
Cancer
Genomics
Immunology
Neurology
Stem Cell
Research
Developmental
Biology
Others
Single-Cell
Genomics Market, End User Outlook (Revenue - USD Million, 2020 - 2033)
Academic
& Research Institutes
Biotechnology
& Pharmaceutical Companies
Hospitals
& Diagnostic Laboratories
Contract
Research Organizations (CROs)
Single-Cell
Genomics Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)
North
America
Europe
Asia
Pacific
Latin
America
Middle East
& Africa
Methodology
Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.
At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.
1. Defining the Research Framework
Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.
2. Robust Data Collection
Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.
3. Advanced Forecasting and Modeling
To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.
4. Data Triangulation and Validation
Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.
5. Quality Assurance and Final Review
Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.
Why Our Methodology Works
What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.
Support Questions
What is the current size of the global single-cell genomics market and what growth is expected??
The global single-cell genomics market was valued at USD 2,042.7 million in 2024 and is projected to reach USD 10,521.7 million by 2033, growing at a CAGR of around 16.7% from 2025 to 2033.
What key product types, technologies and workflows are covered in the market segmentation??
Which applications and end-users are driving this single-cell genomics market??
What are the key drivers, challenges and trends shaping the market??
Which regions dominate the single-cell genomics market, and where is the fastest growth expected??
Related Reports
-
Healthcare Forecast: 2026-2033
Menopause Market Outlook, Growth & CAGR
Global Menopause Market Segmentation, By Treatment Type (Hormone Replacement Therapy (HRT), Non-Hormonal Therapy, Dietary Supplements & Nutraceuti...
-
Healthcare Forecast: 2026-2033
Occupational Rehabilitation Market Report Forecast
Global Occupational Rehabilitation Market Segmentation, By Service Type (Physical Therapy, Occupational Therapy, Vocational Rehabilitation, Ergonomic...
-
Healthcare Forecast: 2026-2033
Global Hospital-at-Home (HaH) Technology Market
Global Hospital-at-Home (HaH) Technology Market Segmentation, By Technology Type (Remote Patient Monitoring Systems, Telehealth & Virtual Care Pla...
-
Healthcare Forecast: 2026-2033
Global Clinical Intelligence Market
Global Clinical Intelligence Market Segmentation, By Application (Clinical Decision Support, Patient Management, Data Analytics, Workflow Optimizati...